Huang S - Search Results

1

ROS-mediated SRMS activation confers platinum resistance in ovarian cancer.

Jiang Y, Song L, Lin Y, Nowialis P, Gao Q, Li T, Li B, Mao X, Song Q, Xing C, Zheng G, Huang S, Jin L. Jiang Y, et al. Among authors: huang s. Oncogene. 2023 May;42(20):1672-1684. doi: 10.1038/s41388-023-02679-6. Epub 2023 Apr 5. Oncogene. 2023. PMID: 37020040 Free PMC article.

2

FAP is critical for ovarian cancer cell survival by sustaining NF-κB activation through recruitment of PRKDC in lipid rafts.

Li B, Ding Z, Calbay O, Li Y, Li T, Jin L, Huang S. Li B, et al. Among authors: huang s. Cancer Gene Ther. 2023 Apr;30(4):608-621. doi: 10.1038/s41417-022-00575-x. Epub 2022 Dec 9. Cancer Gene Ther. 2023. PMID: 36494579 Free PMC article.

3

Signaling of MK2 sustains robust AP1 activity for triple negative breast cancer tumorigenesis through direct phosphorylation of JAB1.

Chen H, Padia R, Li T, Li Y, Li B, Jin L, Huang S. Chen H, et al. Among authors: huang s. NPJ Breast Cancer. 2021 Jul 9;7(1):91. doi: 10.1038/s41523-021-00300-1. NPJ Breast Cancer. 2021. PMID: 34244488 Free PMC article.

4

Addiction to protein kinase Cɩ due to PRKCI gene amplification can be exploited for an aptamer-based targeted therapy in ovarian cancer.

Rehmani H, Li Y, Li T, Padia R, Calbay O, Jin L, Chen H, Huang S. Rehmani H, et al. Among authors: huang s. Signal Transduct Target Ther. 2020 Aug 21;5(1):140. doi: 10.1038/s41392-020-0197-8. Signal Transduct Target Ther. 2020. PMID: 32820156 Free PMC article.

5

Phosphodiesterase 7B/microRNA-200c relationship regulates triple-negative breast cancer cell growth.

Zhang DD, Li Y, Xu Y, Kim J, Huang S. Zhang DD, et al. Among authors: huang s. Oncogene. 2019 Feb;38(7):1106-1120. doi: 10.1038/s41388-018-0499-2. Epub 2018 Sep 12. Oncogene. 2019. PMID: 30209363 Free PMC article.

6

FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib.

Gao L, Wang X, Tang Y, Huang S, Hu CA, Teng Y. Gao L, et al. Among authors: huang s. J Exp Clin Cancer Res. 2017 Jan 9;36(1):8. doi: 10.1186/s13046-016-0478-9. J Exp Clin Cancer Res. 2017. PMID: 28069043 Free PMC article.

7

Epithelial-Mesenchymal Transition Suppresses AMPK and Sensitizes Cancer Cells to Pyroptosis under Energy Stress.

Liang M, Li JW, Luo H, Lulu S, Calbay O, Shenoy A, Tan M, Law BK, Huang S, Xiao TS, Chen H, Wu L, Chang J, Lu J. Liang M, et al. Among authors: huang s. Cells. 2022 Jul 15;11(14):2208. doi: 10.3390/cells11142208. Cells. 2022. PMID: 35883651 Free PMC article.

8

Isoliquiritigenin Inhibits Ovarian Cancer Metastasis by Reversing Epithelial-to-Mesenchymal Transition.

Chen C, Huang S, Chen CL, Su SB, Fang DD. Chen C, et al. Among authors: huang s. Molecules. 2019 Oct 16;24(20):3725. doi: 10.3390/molecules24203725. Molecules. 2019. PMID: 31623144 Free PMC article.

9

Endothelin-1/endothelin A receptor-mediated biased signaling is a new player in modulating human ovarian cancer cell tumorigenesis.

Teoh JP, Park KM, Wang Y, Hu Q, Kim S, Wu G, Huang S, Maihle N, Kim IM. Teoh JP, et al. Among authors: huang s. Cell Signal. 2014 Dec;26(12):2885-95. doi: 10.1016/j.cellsig.2014.08.024. Epub 2014 Sep 3. Cell Signal. 2014. PMID: 25194819 Free PMC article.

10

Simultaneous targeting of CD44 and EpCAM with a bispecific aptamer effectively inhibits intraperitoneal ovarian cancer growth.

Zheng J, Zhao S, Yu X, Huang S, Liu HY. Zheng J, et al. Among authors: huang s. Theranostics. 2017 Mar 23;7(5):1373-1388. doi: 10.7150/thno.17826. eCollection 2017. Theranostics. 2017. PMID: 28435472 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37,651 results

Search Page

Filters